Literature DB >> 16769956

Prospective prevalence of pathologic gambling and medication association in Parkinson disease.

V Voon1, K Hassan, M Zurowski, S Duff-Canning, M de Souza, S Fox, A E Lang, J Miyasaki.   

Abstract

The authors prospectively screened 297 patients with Parkinson disease (PD), who attended a tertiary clinic, using a modified South Oaks Gambling Scale. Lifetime prevalence of pathologic gambling (PG) was 3.4% and on any dopamine agonist was 7.2%. PG was associated with earlier PD onset and with dopamine agonists but not with agonist subtype or doses. We found no association with a potent D3 receptor agonist.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769956     DOI: 10.1212/01.wnl.0000218206.20920.4d

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  78 in total

1.  Zonisamide in managing impulse control disorders in Parkinson's disease.

Authors:  Pedro Emilio Bermejo; Cristina Ruiz-Huete; Buenaventura Anciones
Journal:  J Neurol       Date:  2010-05-28       Impact factor: 4.849

Review 2.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

3.  Pathological gambling in Parkinson's disease.

Authors:  Sui H Wong; Malcolm J Steiger
Journal:  BMJ       Date:  2007-04-21

4.  Long-term follow-up of impulse control disorders in Parkinson's disease.

Authors:  Eugenia Mamikonyan; Andrew D Siderowf; John E Duda; Marc N Potenza; Stacy Horn; Matthew B Stern; Daniel Weintraub
Journal:  Mov Disord       Date:  2008-01       Impact factor: 10.338

Review 5.  [The neurobiology of impulse control disorders].

Authors:  Wendol A Williams; Marc N Potenza
Journal:  Braz J Psychiatry       Date:  2008-01-31       Impact factor: 2.697

Review 6.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

7.  Prevalence of problem and pathological gambling in Parkinson's disease.

Authors:  David Crockford; Jeremy Quickfall; Shawn Currie; Sarah Furtado; Oksana Suchowersky; Nady El-Guebaly
Journal:  J Gambl Stud       Date:  2008-06-17

8.  Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task.

Authors:  Robb B Rutledge; Stephanie C Lazzaro; Brian Lau; Catherine E Myers; Mark A Gluck; Paul W Glimcher
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

9.  [Medical treatment of Parkinson's disease in elderly and multimorbid patients].

Authors:  I Lettow; J Röther
Journal:  Internist (Berl)       Date:  2014-06       Impact factor: 0.743

10.  Hospital care for mental health and substance abuse conditions in Parkinson's disease.

Authors:  Allison W Willis; Dylan P Thibault; Peter N Schmidt; E Ray Dorsey; Daniel Weintraub
Journal:  Mov Disord       Date:  2016-12       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.